The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses Proliferation and Invasion of Human Oral Squamous Carcinoma Cells via p53 Independent and MMP, uPAR Dependent Mechanism-Reference-Cited by-同舟云学术

The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses Proliferation and Invasion of Human Oral Squamous Carcinoma Cells via p53 Independent and MMP, uPAR Dependent Mechanism

Published:2007-01-01 Issue:1 Volume:1095 Page:113-128
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Annals of the New York Academy of Sciences

Author:

LEE E. J.,WHANG J. H.,JEON N. K.,KIM J.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1196/annals.1397.015/fullpdf

Reference20 articles.

1. Advances in Chemoprevention of Head and Neck Cancer

2. Head and Neck Cancer

3. Second Primary Malignancies in the Head and Neck Cancer Patient

4. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model;Recent Patents on Anti-Cancer Drug Discovery;2024-08

2. Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression;Anticancer Research;2022-07

3. Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment;Molecular Oncology;2020-10-05

4. Oncogenic gene RGC‐32 is a direct target of miR‐26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling;Cell Biochemistry and Function;2020-04-23

5. EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells;EBioMedicine;2019-01